Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ — Sparta Biomedical, a private medical device company focused on osteoarthritis repair solutions, today announced that it has successfully implanted its Ormi device in patients with focal knee lesions as part of its first-in-human... Read More →
Remedee Labs’ Solution becomes the first CE marked medical device (class IIa) approved for the treatment of fibromyalgia in Europe
PARIS, Sept. 16, 2024 /PRNewswire/ — Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain, is announcing today that it has obtained medical device status in Europe for its millimeter wave endorphin stimulator wristband. The Remedee... Read More →
X-Bolt Receives Prestigious ‘Best Technology in Spine’ Award from Orthopedics This Week
DUBLIN, Sept. 16, 2024 /PRNewswire/ — X-Bolt Orthopedics, an emerging innovator of bone fixation implants in orthopedics, has been awarded the Best Technology In Spine Award for 2024/2025 by Orthopedics This Week. This award honors the unsung heroes in the... Read More →
Darmiyan, Inc. Announces Launch of Groundbreaking BrainSee Platform for Alzheimer’s Testing
SAN FRANCISCO, Sept. 16, 2024 /PRNewswire/ — Darmiyan, Inc., a pioneer in brain technology, is proud to announce the launch of the BrainSee Platform, integrating the first-of-its-kind FDA-approved BrainSee Test for Alzheimer’s disease. This innovative platform is designed to revolutionize... Read More →
DASI Simulations earns FDA clearance for second AI-powered imaging product; continues to build structural heart platform
DASI Dimensions offers AI-powered, accurate, efficient pre-procedural measurement for heart valve replacement DUBLIN, OH, UNITED STATES, September 10, 2024 /EINPresswire.com/ — DASI Simulations announced today that its second product – DASI Dimensions – has earned FDA clearance. “Our mission –... Read More →
EXCLUSIVE: Bloomlife Secures $12.2M Series A to Advance Remote Maternal Care Platform
Bloomlife, a leader in maternal health technology, has successfully raised $12.2 million in a Series A funding round, marking a significant step forward in its mission to advance maternal healthcare. The funding round was led by Kapor Capital and European... Read More →
Discure Technologies Announces $16 Million in Financing Led by BOLD Capital Partners, Supernova Invest and Sanara Capital
Funds will advance the clinical testing of Discure’s breakthrough device for degenerative disc disease PETACH-TIKVA, Israel, Sept. 10, 2024 /PRNewswire/ — Discure Technologies Ltd., developer of the Discure System, a bioelectronic implantable device for the treatment of degenerative disc disease... Read More →
GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research
Half Moon Bay, CA – September 10, 2024 – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural biology research for biopharmaceutical companies. The integration of GenNext’s AutoFox Protein Footprinting System with... Read More →
HEPTA Medical Secures €5.7 Million Series A, Led by BPI France to Advance Minimally Invasive Lung Cancer Treatment
Founded in 2019 by Sofinnova’s medtech acceleration team, MD Start The funds will be used for the 510(k) regulatory approval process for the first version of HEPTA Medical’s microwave ablation platform and to initiate its clinical trials SURESNES, France–(BUSINESS WIRE)–HEPTA... Read More →
Lungpacer Medical Announces PMA Submission for AeroPace® System
AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy designed for quicker liberation from mechanical ventilation FOR IMMEDIATE RELEASE Exton, PA – September 4, 2024 – Lungpacer Medical, a neurostimulation company developing interventional therapies to free patients from mechanical... Read More →